Parenteral product quality is improving. Since 2014, when USP <790> “Visible Particulates in Injections” (1) became official, particle-related recalls of injectable products have dropped significantly ...
Automatic visual inspection machines and artificial intelligence highlight inspection deficits for parenteral containers and units. As a mandatory practice for injectable drug products by both FDA and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback